DOSAGE INDEX / BLEND
Neuroxelin
Research, reported schedules and supply planning.
Understand Neuroxelin ingredient listings, modified-peptide distinctions and the evidence needed to support a finished cognitive-research blend.
Source: PeptideDosages.com. Independently written summaries of reported protocols, not validated treatment recommendations. Reviewed for transcription on September 21, 2026.
Research Protocol & Dosage
Source-reported examples · not treatment recommendations
- Amount
- 250–1,000 micrograms total per day; its main starting example is 500 micrograms
- Frequency
- Once daily
- Cycle / observation period
- 8–12 weeks
- Route / research model
- Subcutaneous
This is a source-reported blend. The identity and proportions of the actual supplied formulation must be documented before any comparison.
Titration & progression
A dose range is not a titration schedule. No independently verified stepwise escalation has been established for this source-reported regimen.
Supply & Planning
Compare vial strengths here. A different vial size changes the available material, not the biological dose.
Diluent & formulation
Diluent compatibility is formulation-specific. A verified manufacturer instruction is still needed before bacteriostatic water or another diluent can be listed as suitable for this research material.
Vial comparison
No single complete schedule is resolved for this entry. Enter a documented total to compare strengths; the calculator does not select a regimen.
| Vial strength | Vials needed |
|---|---|
| 48 mg | Enter a total |
Enter a positive material total.
Material minimum only: round total material ÷ vial content up to a whole vial. Actual supply may be higher because of single-use packaging, discard dates, dead space or losses. No validated multi-use storage period is assumed.
Reported Research Results
Selected observations from the cited research. Each finding retains its study population, formulation and limitations.
Studies of individual ingredients do not establish the effects of this finished combination. Combination studies are identified explicitly below.
- The reference catalog describes Neuroxelin as a blend of PE-22-28, Pinealon, N-acetyl Semax and N-acetyl Selank. That description documents the listed formula; it does not verify the contents of a particular product or establish the combination's efficacy. This review did not match a direct outcome study of that exact finished blend.
- The catalog specifically names N-acetyl Semax and N-acetyl Selank. Omitting the modification in a summary would erase an identity distinction in the described formula.
Sourcing & Vendor Information
No compound-specific affiliate destination is listed here yet. Browse the Vendors Index for the available supplier records and disclosed relationships.
Sources & Further Reading
Medical publications and supporting literature from the corresponding protocol bibliographies, combined across vial strengths. Supplier and commercial catalog references are excluded. Duplicate destinations appear once. Inclusion does not mean that a paper validates the reported dose, or that an ingredient study tests the finished blend.
Bibliography checked September 22, 2026: 14 entries mapped from 1 source page. Medical and supporting references are retained below; supplier entries are excluded.
- The LancetFurther reading · Listed in reference bibliography.
- Scientific Reports (Nature)Further reading · Listed in reference bibliography.
- Drugs (Springer/PubMed)Further reading · Listed in reference bibliography.
- Nutrients (PMC)Further reading · Listed in reference bibliography.
- NIBSC (UK MHRA)Further reading · Listed in reference bibliography.
- Biochimica et Biophysica Acta (ScienceDirect)Further reading · Listed in reference bibliography.
- Stroke (AHA Journals)Further reading · Listed in reference bibliography.
- PubMedFurther reading · Listed in reference bibliography.
- CDCGeneral guidance · Listed in reference bibliography.
- CDCGeneral guidance · Listed in reference bibliography.
- Advances in Therapy (PMC)Further reading · Listed in reference bibliography.
- Translational Psychiatry (Nature)Further reading · Listed in reference bibliography.
- Schizophrenia Research (ScienceDirect)Further reading · Listed in reference bibliography.
Reported schedule reference: PeptideDosages.com. Research findings are summarized independently from the listed sources.